The new guidance offers improved clarity on disclosure in the prospectus and suitability for listing of biotech companies.
Since the implementation of the new listing regime for biotech companies under Chapter 18A of the...more
Hong Kong Stock Exchange introduces new listing regime for pre-revenue biotech companies and innovative companies with weighted voting rights structures.
...more